ArticleActa neurochirurgica2025
Intraoperative use of lateral spread response measurement in the upper orbicularis oculi and mandibular muscles in patients with hemifacial spasm after botulinum toxin treatment.
Article in Acta neurochirurgica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The application value of intraoperative lateral spreading response monitoring during microvascular decompression in patients with primary hemifacial spasm.European journal of medical research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFollowing repeated botulinum toxin (BTX) treatments, patients with hemifacial spasm (HFS) are recommended to undergo microvascular decompression (MVD) for a permanent cure. Intraoperative lateral spread response (LSR) monitoring is important to improve surgical outcomes. However, LSR monitoring during MVD surgery in HFS patients who have previously received BTX is challenging, since the muscles typically used to assess the LSR are paralyzed. Here, we describe our use of the upper part of the orbicularis oculi and mentalis muscles for intraoperative monitoring of the LSR during MVD in HFS patients following BTX treatment.
methodsHFS patients who underwent MVD surgery were divided into two groups based on their history of BTX treatment: BTX+ and BTX- groups. In the BTX+ group, MVD was performed at least 3 months after the last BTX injection. We measured LSR morphology, including the number of spikes, their duration, and maximum amplitude in all patients. We also measured intraoperative LSR disappearance rate, and the cure rate of HFS at the final follow-up (over 1 year after surgery).
resultsAlthough the waveforms showed a trend toward shorter durations with mandibular branch stimulation in the BTX+ group, there was no difference in the number of spikes or maximum amplitude values. There was no increase in LSR dysmetria after BTX treatment (BTX+ group: 32.8% vs. BTX- group: 31.9%). There was also no difference in intraoperative LSR disappearance rate between the two groups (BTX+ group: 68.3% vs. BTX- group: 74.6%).
conclusionIntraoperative LSR monitoring using the upper part of the orbicularis oculi muscle and the mentalis muscle at an interval of at least 3 months after the last BTX treatment might be a feasible monitoring technique during MVD for HFS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.